Dr David Hughes has been appointed to the board of directors, effective immediately. He will also continue with his responsibility for overseeing
CN Bio Innovations features in Al Jazeera documentary “The Cure”
Welwyn Garden City, UK, 11 August 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms, was featured in the 10 August
CN Bio Innovations announces deal with sixth pharmaceutical collaborator in 2015 and features in The Economist
Welwyn Garden City, UK, 12 June 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for
CN Bio Innovations announces research collaboration with Alnylam
CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics for liver diseases and infection, is
CN Bio Innovations announces LiverChip research study with leading pharmaceutical company
Welwyn Garden City, UK, 27th May 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics
Bloomberg and Businessweek feature CN Bio Innovations’ LiverChip Platform
CN Bio’s flagship liver on a chip platform, LiverChip, has been featured both in a technology snapshot in the March 23rd issue of Businessweek and in
CN Bio Innovations announces Hepatitis B research collaboration with leading pharmaceutical company
Welwyn Garden City, UK, 21st April 2015: CN Bio Innovations, an expert in developing human organ-on-a-chip platforms to test and develop therapeutics
CN Bio announces research collaboration with antisense discovery pioneers Isis Pharmaceuticals
CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased
CN Bio announces research collaboration with gene silencing specialist Benitec Biopharma
CN Bio Innovations, an expert in developing human biomimetic platforms to test and develop therapeutics for liver diseases and infection, is pleased